These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31862814)

  • 1. Is dapsone still relevant in immune thrombocytopenia in resource limited settings?
    Dalal P; Gulia M; Gupta M; Tahlan A
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31862814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone treatment in a girl with severe chronic thrombocytopenic purpura. Does it work? Do not touch it!
    Pusiol A; Nocerino A; Passone E; Tenore A
    Minerva Pediatr; 2012 Oct; 64(5):545-7. PubMed ID: 22992536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
    Rodrigo C; Gooneratne L
    J Thromb Haemost; 2013 Nov; 11(11):1946-53. PubMed ID: 23927583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone for autoimmune thrombocytopenic purpura.
    Godeau B; Oksenhendler E; Bierling P
    Am J Hematol; 1993 Sep; 44(1):70-2. PubMed ID: 8342569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone for immune thrombocytopenic purpura in children and adults.
    Patel AP; Patil AS
    Platelets; 2015; 26(2):164-7. PubMed ID: 24512442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapsone for paediatric chronic immune thrombocytopenia: Short report from a tertiary centre in South India.
    Bharadwaj N; Munireddy J; Selvam S; Bharadwaj V; Prakash A
    Br J Haematol; 2024 Mar; 204(3):1024-1028. PubMed ID: 38220217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
    Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
    BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases.
    Godeau B; Durand JM; Roudot-Thoraval F; Tennezé A; Oksenhendler E; Kaplanski G; Schaeffer A; Bierling P
    Br J Haematol; 1997 May; 97(2):336-9. PubMed ID: 9163598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune thrombocytopenic purpura presenting with spontaneous gingival haemorrhage in pregnancy.
    Dunphy L; Williams R
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30659003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
    Zaja F; Marin L; Chiozzotto M; Puglisi S; Volpetti S; Fanin R
    Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age old dapsone in the treatment of idiopathic thrombocytopenic purpura--a case report with review.
    Kundu R; Sethi N; Ghose A; Chaudhary R
    Am J Ther; 2013; 20(6):e723-5. PubMed ID: 21822117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of immune thrombocytopenia: a retrospective study of 40 patients].
    Audia S; Lakomy D; Guy J; Leguy-Seguin V; Berthier S; Aho S; Lorcerie B; Bonnotte B
    Rev Med Interne; 2010 May; 31(5):337-44. PubMed ID: 20409619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.
    Estève C; Samson M; Guilhem A; Nicolas B; Leguy-Seguin V; Berthier S; Bonnotte B; Audia S
    PLoS One; 2017; 12(10):e0187296. PubMed ID: 29084292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we manage immune thrombocytopenia in the elderly.
    Mahévas M; Michel M; Godeau B
    Br J Haematol; 2016 Jun; 173(6):844-56. PubMed ID: 27062054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there still a place for "old therapies" in the management of immune thrombocytopenia?
    Audia S; Godeau B; Bonnotte B
    Rev Med Interne; 2016 Jan; 37(1):43-9. PubMed ID: 26422785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic immune thrombocytopenic purpura. Looking for something better. Review].
    Vizcaíno G; Diez-Ewald M; Vizcaíno-Carruyo J
    Invest Clin; 2009 Mar; 50(1):95-108. PubMed ID: 19418731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients.
    Damodar S; Viswabandya A; George B; Mathews V; Chandy M; Srivastava A
    Eur J Haematol; 2005 Oct; 75(4):328-31. PubMed ID: 16146539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response.
    Colella MP; Orsi FA; Alves ECF; Delmoro GF; Yamaguti-Hayakawa GG; de Paula EV; Annichino-Bizzacchi JM
    J Thromb Haemost; 2021 Sep; 19(9):2275-2286. PubMed ID: 34018665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone for refractory chronic idiopathic thrombocytopenic purpura.
    Hernández F; Linares M; Colomina P; Pastor E; Cerveró A; Pérez A; Perella M
    Br J Haematol; 1995 Jun; 90(2):473-5. PubMed ID: 7794776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.